Searched for
JARDIANCE
Ray J performs with blood-like streak on face and medical patch on chest - watch videoRay J's recent performance has sparked worry among fans. Videos show him with a drop of blood on his cheek and a medical dressing on his ch...- Drugmakers raise US prices on 350 medicines despite pressure from Donald TrumpDrug companies are set to increase prices on over 350 medicines. This includes vital vaccines and cancer drugs. The median price hike is ar...
- Weight-loss drug Mounjaro crosses Rs 100 crore sales in 4 monthsThe drug clocked Rs 47-crore sales in July, double its June figure, according to data from prescriptions tracker PharmaTrac. If this month-...
- As Empagliflozin goes off patent, 71 copies of the key diabetes drug roll out in a monthFollowing the expiration of Empagliflozin's patent, the Indian pharmaceutical market has seen a surge, with 71 new brands and 17 companies ...
- New affordable diabetes drug Empagliflozin launched in IndiaSeveral domestic drug makers, including Mankind Pharma, have launched the diabetes drug Empagliflozin at significantly reduced prices follo...
- White House says deals struck to cut prices of popular Medicare drugs that cost $50 billion yearlyThe Biden administration announced agreements with drug companies to lower the cost of 10 major Medicare medications, potentially saving ta...
- Boehringer's Jardiance now gets CDSCO nod for chronic kidney diseaseThe Central Drugs Standard Control Organisation of India has approved Jardiance, a 10mg dosage form of empagliflozin, for the treatment of ...
- US names first 10 drugs for Medicare price negotiationThe Biden administration has released a list of 10 prescription medicines that will be subject to price negotiations by the U.S. Medicare h...
- Boehringer Ingelheim obtains interim injunction against four Indian drug cos from selling its diabetes drugBI said the injunctions restrain the domestic pharma companies from infringing the patent of Linagliptin by advertising, launching, making,...
- Boehringer Ingelheim gets CDSCO nod for Jardiance to treat for new heart failure indicationJardiance is the top selling drug of BI in India, used in treatment of type-2 diabetes and for the treatment of heart failure with reduced ...
- Himachal Pradesh high court restrains DRL from selling BI's diabetic drug JardianceThe drugmaker said it is reviewing legal options including filing an appeal against the court order. Dr Reddy's has launched copies of Jard...
- Boehringer Ingelheim's diabetes pill Jardiance gets CDSCO nod for use against heart failureGerman drug maker Boehringer Ingelheim has won approval from the Indian drug regulator to market its top-selling type-2 diabetes medication...
- Boehringer Ingelheim gets interim injunction against Dr. Reddy’s Labs, MSN Labs against copies of anti-diabetes drugIn a statement to ET, BI confirmed it has obtained separate orders granting ad-interim injunction that restrains the two domestic pharmaceu...
- MSN Labs launches patented diabetes pill Jardiance after DRL, heats up potential legal battleEarlier, ET reported that Dr Reddy's Labs has launched copies of Jardiance. It has a valid patent in India until 2025.
- Dr Reddy's Labs launches copy of BI drug; move may lead to legal battleUnder its brand Vicra, Dr. Reddy's is expected to sell the drug in India at less than a third of the price charged by Boehringer Ingelheim....
- Pharma may see a price war in good news for diabeticsGlenmark launches a drug at almost half the price of those offered by rivals.
- Patented drug launches help MNCs score over Indian peersWhile Indian companies still control almost 80% of the market in the country, the strategy of launching specialised patented product is hel...
- Boehringer Ingelheim India and Lupin enter agreement to market diabetes drugIMS values the Indian diabetes market is at Rs9,003 crore and has recorded it as growing at 19.5%, according to a release by Lupin.
- Sun Pharma, AstraZeneca tie up to sell latest anti-diabetes drug DapagliflozinDiabetes estimated to affect approximately 69.2 million people in India and more than 415 million people worldwide.
- Boehringer Igelheim aims for top slot with anti-diabetes drug launchWith Jardiance, BI has the advantage of significantly reducing cardiovascular risks associated with most patients with diabetes.
Load More
